Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-07-24 Sale | 2023-07-25 4:25 pm | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 33,789 | $4.83 | $163,201 | 81,925 (Direct) | View |
2023-07-24 Sale | 2023-07-25 4:23 pm | Verrica Pharmaceuticals Inc. | VRCA | Goldenberg Gary Chief Medical Officer | 28,699 | $4.83 | $138,616 | 70,110 (Direct) | View |
2023-07-24 Sale | 2023-07-25 4:22 pm | Verrica Pharmaceuticals Inc. | VRCA | Bonaccorso Joe Chief Commercial Officer | 38,262 | $4.83 | $184,805 | 62,738 (Direct) | View |
2023-07-24 Sale | 2023-07-25 4:18 pm | Verrica Pharmaceuticals Inc. | VRCA | White Ted President and CEO | 50,677 | $4.83 | $244,770 | 128,789 (Direct) | View |
2023-07-24 Purchase | 2023-07-24 6:47 pm | Verrica Pharmaceuticals Inc. | VRCA | Manning Paul B Director 10% Owner | 200,000 | $5.02 | $1,004,000 | 15,589,481 (Indirect Direct) | View |
2022-07-05 Purchase(A) | 2023-02-21 4:08 pm | Verrica Pharmaceuticals Inc. | VRCA | White Ted President and CEO | 7,500 | $2.1 | $15,750 | 29,466 (Direct) | View |
2022-07-11 Purchase | 2022-07-11 5:24 pm | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 7,500 | $3.4 | $25,500 | 15,714 (Direct) | View |
2022-07-05 Purchase | 2022-07-05 5:32 pm | Verrica Pharmaceuticals Inc. | VRCA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner | 1,428,571 | $2.1 | $2,999,999 | 5,038,983 (Indirect) | View |
2022-07-05 Purchase | 2022-07-05 4:13 pm | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 5,714 | $2.1 | $11,999 | 8,214 (Direct) | View |
2022-07-05 Purchase | 2022-07-05 4:13 pm | Verrica Pharmaceuticals Inc. | VRCA | White Ted President and CEO | 23,809 | $2.1 | $49,999 | 29,466 (Direct) | View |
2022-07-05 Purchase | 2022-07-05 4:12 pm | Verrica Pharmaceuticals Inc. | VRCA | Goldenberg Gary Chief Medical Officer | 23,809 | $2.1 | $49,999 | 23,809 (Direct) | View |
2022-07-05 Purchase | 2022-07-05 4:11 pm | Verrica Pharmaceuticals Inc. | VRCA | Stalfort John A III Director | 238,095 | $2.1 | $500,000 | 700,205 (Direct) | View |
2022-07-05 Purchase | 2022-07-05 4:10 pm | Verrica Pharmaceuticals Inc. | VRCA | Manning Paul B Director 10% Owner | 4,761,904 | $2.1 | $9,999,998 | 15,389,481 (Indirect Direct) | View |
2021-12-02 Purchase | 2021-12-06 08:20 am | Verrica Pharmaceuticals Inc. | VRCA | Manning Paul B Director 10% Owner | 50,000 | $9.3581 | $467,905 | 10,627,577 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-08-24 Option Award | 2023-08-28 4:40 pm | N/A N/A | Verrica Pharmaceuticals Inc. | VRCA | Kohler Terry Chief Financial Officer | 62,500 | $0 | 62,500 (Direct) | View |
2023-08-24 Option Award | 2023-08-28 4:39 pm | N/A N/A | Verrica Pharmaceuticals Inc. | VRCA | White Ted President and CEO | 75,000 | $0 | 203,789 (Direct) | View |
2023-08-24 Option Award | 2023-08-28 4:39 pm | N/A N/A | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 75,000 | $0 | 156,925 (Direct) | View |
2023-08-24 Option Award | 2023-08-28 4:38 pm | N/A N/A | Verrica Pharmaceuticals Inc. | VRCA | Goldenberg Gary Chief Medical Officer | 25,000 | $0 | 95,110 (Direct) | View |
2023-08-24 Option Award | 2023-08-28 4:37 pm | N/A N/A | Verrica Pharmaceuticals Inc. | VRCA | Bonaccorso Joe Chief Commercial Officer | 62,500 | $0 | 125,238 (Direct) | View |
2023-07-21 Option Award | 2023-07-25 4:25 pm | N/A N/A | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 100,000 | $0 | 81,925 (Direct) | View |
2023-07-21 Option Award | 2023-07-25 4:23 pm | N/A N/A | Verrica Pharmaceuticals Inc. | VRCA | Goldenberg Gary Chief Medical Officer | 75,000 | $0 | 70,110 (Direct) | View |
2023-07-21 Option Award | 2023-07-25 4:22 pm | N/A N/A | Verrica Pharmaceuticals Inc. | VRCA | Bonaccorso Joe Chief Commercial Officer | 100,000 | $0 | 62,738 (Direct) | View |
2023-07-21 Option Award | 2023-07-25 4:18 pm | N/A N/A | Verrica Pharmaceuticals Inc. | VRCA | White Ted President and CEO | 150,000 | $0 | 128,789 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 09:05 am | N/A 2033-06-07 | Verrica Pharmaceuticals Inc. | VRCA | Ballaron Craig Director | 10,384 | $0 | 10,384 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 09:03 am | N/A 2033-06-07 | Verrica Pharmaceuticals Inc. | VRCA | Eichenfield Lawrence Director | 10,384 | $0 | 10,384 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 09:03 am | N/A 2033-06-07 | Verrica Pharmaceuticals Inc. | VRCA | Nguyen Diem Director | 10,384 | $0 | 10,384 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 09:02 am | N/A 2033-06-07 | Verrica Pharmaceuticals Inc. | VRCA | PRYGOCKI MARK A SR Director | 10,384 | $0 | 10,384 (Direct) | View |
2023-03-01 Option Award | 2023-03-03 4:29 pm | N/A 2033-02-28 | Verrica Pharmaceuticals Inc. | VRCA | White Ted President and CEO | 240,000 | $0 | 240,000 (Direct) | View |
2023-03-01 Option Award | 2023-03-03 4:28 pm | N/A 2033-02-28 | Verrica Pharmaceuticals Inc. | VRCA | Bonaccorso Joe Chief Commercial Officer | 85,000 | $0 | 85,000 (Direct) | View |
2023-03-01 Option Award | 2023-03-03 4:27 pm | N/A 2033-02-28 | Verrica Pharmaceuticals Inc. | VRCA | Kohler Terry Chief Financial Officer | 85,000 | $0 | 85,000 (Direct) | View |
2023-03-01 Option Award | 2023-03-03 4:26 pm | N/A 2033-02-28 | Verrica Pharmaceuticals Inc. | VRCA | Goldenberg Gary Chief Medical Officer | 85,000 | $0 | 85,000 (Direct) | View |
2023-03-01 Option Award | 2023-03-03 4:25 pm | N/A 2033-02-28 | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 135,000 | $0 | 135,000 (Direct) | View |
2022-06-09 Option Award | 2022-06-13 4:20 pm | N/A 2032-06-08 | Verrica Pharmaceuticals Inc. | VRCA | Ballaron Craig Director | 10,384 | $0 | 10,384 (Direct) | View |
2022-06-09 Option Award | 2022-06-13 4:18 pm | N/A 2032-06-08 | Verrica Pharmaceuticals Inc. | VRCA | PRYGOCKI MARK A SR Director | 10,384 | $0 | 10,384 (Direct) | View |
2022-06-09 Option Award | 2022-06-13 4:17 pm | N/A 2032-06-08 | Verrica Pharmaceuticals Inc. | VRCA | Eichenfield Lawrence Director | 10,384 | $0 | 10,384 (Direct) | View |
2022-06-09 Option Award | 2022-06-13 4:16 pm | N/A 2032-06-08 | Verrica Pharmaceuticals Inc. | VRCA | Nguyen Diem Director | 10,384 | $0 | 10,384 (Direct) | View |
2022-02-24 Option Award | 2022-02-25 4:37 pm | N/A 2032-02-23 | Verrica Pharmaceuticals Inc. | VRCA | Hayes Christopher G. Chief Legal Officer | 75,000 | $0 | 75,000 (Direct) | View |
2022-02-24 Option Award | 2022-02-25 4:36 pm | N/A 2032-02-23 | Verrica Pharmaceuticals Inc. | VRCA | Goldenberg Gary Chief Medical Officer | 75,000 | $0 | 75,000 (Direct) | View |
2022-02-24 Option Award | 2022-02-25 4:33 pm | N/A 2032-02-23 | Verrica Pharmaceuticals Inc. | VRCA | Kohler Terry Chief Financial Officer | 75,000 | $0 | 75,000 (Direct) | View |
2022-02-24 Option Award | 2022-02-25 4:33 pm | N/A 2032-02-23 | Verrica Pharmaceuticals Inc. | VRCA | Bonaccorso Joe Chief Commercial Officer | 75,000 | $0 | 75,000 (Direct) | View |
2022-02-24 Option Award | 2022-02-25 4:30 pm | N/A 2032-02-23 | Verrica Pharmaceuticals Inc. | VRCA | White Ted President and CEO | 200,000 | $0 | 200,000 (Direct) | View |
2021-07-06 Ownership | 2022-02-14 9:15 pm | N/A N/A | Verrica Pharmaceuticals Inc. | VRCA | Manning Paul B Director 10% Owner | 739,830 | $0 | 8,889,224 (Indirect) | View |
2021-07-16 Option Award | 2021-07-20 6:04 pm | N/A 2031-07-15 | Verrica Pharmaceuticals Inc. | VRCA | Kohler Terry Chief Financial Officer | 125,000 | $0 | 125,000 (Direct) | View |